Distribution and Synthesis of Apolipoprotein J in the Atherosclerotic Aorta

From the Department of Pathology, Toho University School of Medicine (Y.I., Y.A., T.I.); the Department of Pathology, School of Dentistry, Nihon University (K.K.); the Department of Pathology, Hachioji Medical Center, Tokyo Medical College (S.M., N.A.); and the Department of Physiological Chemistry, School of Pharmaceutical Sciences, Showa University (N.-H.C.-M., M.T.), Tokyo, Japan.

Correspondence to Yukio Ishikawa, MD, Department of Pathology, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, Tokyo 143-8450 Japan. Email yukio{at}med.toho-u.ac.jp

Abstract—The distribution of apolipoprotein (apo) J during the development of atherosclerosis in the human aorta was evaluated by immununohistochemical observation, together with the other apolipoprotein A-I, A-II, B, C-III, and E. Although apoJ was never observed in the normal aorta (ie, without any intimal lesions or intimal thickening), it was distributed not only in the intima but also in the media of aortas with diffuse, intimal thickening or atherosclerotic lesions. Double immunostaining with antibodies for apoJ and -smooth muscle actin revealed apoJ deposition in smooth muscle cells (SMCs) or the aortic stroma in the vicinity of SMCs. The extent of apoJ distribution in the aortic wall increased with the degree of atherosclerosis development. In addition, the distribution pattern of apoJ was very similar to that of apoA-I and E. In situ hybridization with human apoJ cDNA demonstrated intense signals in cells scattered within the subendothelial space and medial SMCs of the aorta with advanced atherosclerosis but not in those of the normal aorta without intimal thickening. Furthermore, reverse transcriptase–polymerase chain reaction of the cultured human aortic SMCs revealed apoJ mRNA expression in these cells. The results indicate that apoJ in the aortic wall originates from not only apoJ circulated in the plasma but also apoJ produced by SMCs in the aortic wall. Considering the similarities of the distribution between apoJ and apo-A-I or E, we hypothesize that apoJ possibly has a protective role against human atherosclerosis by its involvement with cholesterol transport from the aortic wall to the liver.

Key Words: apolipoprotein J • apolipoproteins • human aorta • atherosclerosis • in situ hybridization

This article has been cited by other articles:

				M. V. Poulakou, K. I. Paraskevas, I. S. Vlachos, S.-A. P. Karabina, M. R. Wilson, D. C. Iliopoulos, S. I. Tsitsilonis, D. P. Mikhailidis, and D. N. Perrea Effect of Statins on Serum Apolipoprotein J and Paraoxonase-1 Levels in Patients With Ischemic Heart Disease Undergoing Coronary Angiography Angiology, May 1, 2008; 59(2): 137 - 144. [Abstract] [PDF]

				P. A. J. Krijnen, S. A. G. M. Cillessen, R. Manoe, A. Muller, C. A. Visser, C. J. L. M. Meijer, R. J. P. Musters, C. E. Hack, L. A. Aarden, and H. W. M. Niessen Clusterin: a protective mediator for ischemic cardiomyocytes? Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2193 - H2202. [Abstract] [Full Text] [PDF]

				T. Criswell, M. Beman, S. Araki, K. Leskov, E. Cataldo, L. D. Mayo, and D. A. Boothman Delayed Activation of Insulin-like Growth Factor-1 Receptor/Src/MAPK/Egr-1 Signaling Regulates Clusterin Expression, a Pro-survival Factor J. Biol. Chem., April 8, 2005; 280(14): 14212 - 14221. [Abstract] [Full Text] [PDF]

				A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res., March 1, 2005; 46(3): 389 - 403. [Abstract] [Full Text] [PDF]

				A. Orlandi, S. Pucci, A. Ciucci, F. Pichiorri, A. Ferlosio, and L. G. Spagnoli Modulation of Clusterin Isoforms Is Associated With All-Trans Retinoic Acid-Induced Proliferative Arrest and Apoptosis of Intimal Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 348 - 353. [Abstract] [Full Text] [PDF]

				M. Miyata, S. Biro, H. Kaieda, H. Eto, K. Orihara, T. Kihara, H. Obata, N. Matsushita, T. Matsuyama, and C. Tei Apolipoprotein J/Clusterin Is Induced in Vascular Smooth Muscle Cells After Vascular Injury Circulation, September 18, 2001; 104(12): 1407 - 1412. [Abstract] [Full Text] [PDF]

				E. S. Lymar, A. M. Clark, R. Reeves, and M. D. Griswold Clusterin Gene in Rat Sertoli Cells Is Regulated by a Core-Enhancer Element Biol Reprod, November 1, 2000; 63(5): 1341 - 1351. [Abstract] [Full Text]

				H. Ueno, P. Kanellakis, A. Agrotis, and A. Bobik Blood Flow Regulates the Development of Vascular Hypertrophy, Smooth Muscle Cell Proliferation, and Endothelial Cell Nitric Oxide Synthase in Hypertension Hypertension, July 1, 2000; 36(1): 89 - 96. [Abstract] [Full Text] [PDF]

				T. Kanaki, H. Bujo, S. Hirayama, I. Ishii, N. Morisaki, W. J. Schneider, and Y. Saito Expression of LR11, a Mosaic LDL Receptor Family Member, Is Markedly Increased in Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2687 - 2695. [Abstract] [Full Text] [PDF]